Kuan-Lin Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kuan-Lin Wu has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Han Xiao
Department of Chemistry, Rice University, Houston, USA
3 shared publications - George N. Phillips
Department of Biosciences, Rice University, Houston, TX 77005, USA
2 shared publications - Mitchell D. Miller
Department of BioSciences, Rice University, Houston, TX, USA
2 shared publications - Yuda Chen
Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA
2 shared publications - Andrea Lia
Institute of Sciences of Food Production, C.N.R. Unit of Lecce, via Monteroni, I-73100 Lecce, Italy
1 shared publication - Andrew Lee Lovering
School of Biosciences, University of Birmingham, Birmingham, UK
1 shared publication
Latest Publications
- Open Access
- 26 July 2023
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 91 (12) , 1571-1599
Protein target highlights in CASP15: Analysis of models by structure providers
We present an in‐depth analysis of selected CASP15 targets, focusing on their biological and functional significance. The authors of the structures identify and discuss key protein features and evaluate how effectively these aspects were captured in the submitted predictions. While the overall ability to predict three‐dimensional protein structures continues to impress, reproducing uncommon features not previously observed in experimental structures is still a challenge. Furthermore, instances with conformational flexibility and large multimeric complexes highlight the need for novel scoring strategies to better emphasize biologically relevant structural regions. Looking ahead, closer integration of computational and experimental techniques will play a key role in determining the next challenges to be unraveled in the field of structural molecular biology.
- 26 July 2023
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 91 (12) , 1571-1599
Open AccessProtein target highlights in CASP15: Analysis of models by structure providers
We present an in‐depth analysis of selected CASP15 targets, focusing on their biological and functional significance. The authors of the structures identify and discuss key protein features and evaluate how effectively these aspects were captured in the submitted predictions. While the overall ability to predict three‐dimensional protein structures continues to impress, reproducing uncommon features not previously observed in experimental structures is still a challenge. Furthermore, instances with conformational flexibility and large multimeric complexes highlight the need for novel scoring strategies to better emphasize biologically relevant structural regions. Looking ahead, closer integration of computational and experimental techniques will play a key role in determining the next challenges to be unraveled in the field of structural molecular biology.
- 28 September 2022
- Published by Wiley in Protein Science
- Vol. 31 (10) , e4443
Expanding the eukaryotic genetic code with a biosynthesized 21st amino acid
Genetic code expansion technology allows for the use of noncanonical amino acids (ncAAs) to create semisynthetic organisms for both biochemical and biomedical applications. However, exogenous feeding of chemically synthesized ncAAs at high concentrations is required to compensate for the inefficient cellular uptake and incorporation of these components into proteins, especially in the case of eukaryotic cells and multicellular organisms. To generate organisms capable of autonomously biosynthesizing an ncAA and incorporating it into proteins, we have engineered a metabolic pathway for the synthesis of O‐methyltyrosine (OMeY). Specifically, we endowed organisms with a marformycins biosynthetic pathway‐derived methyltransferase that efficiently converts tyrosine to OMeY in the presence of the co‐factor S‐adenosylmethionine. The resulting cells can produce and site‐specifically incorporate OMeY into proteins at much higher levels than cells exogenously fed OMeY. To understand the structural basis for the substrate selectivity of the transferase, we solved the X‐ray crystal structures of the ligand‐free and tyrosine‐bound enzymes. Most importantly, we have extended this OMeY biosynthetic system to both mammalian cells and the zebrafish model to enhance the utility of genetic code expansion. The creation of autonomous eukaryotes using a 21st amino acid will make genetic code expansion technology more applicable to multicellular organisms, providing valuable vertebrate models for biological and biomedical research.
- 28 September 2022
- Published by Wiley in Protein Science
- Vol. 31 (10) , e4443
Expanding the eukaryotic genetic code with a biosynthesized 21st amino acid
Genetic code expansion technology allows for the use of noncanonical amino acids (ncAAs) to create semisynthetic organisms for both biochemical and biomedical applications. However, exogenous feeding of chemically synthesized ncAAs at high concentrations is required to compensate for the inefficient cellular uptake and incorporation of these components into proteins, especially in the case of eukaryotic cells and multicellular organisms. To generate organisms capable of autonomously biosynthesizing an ncAA and incorporating it into proteins, we have engineered a metabolic pathway for the synthesis of O‐methyltyrosine (OMeY). Specifically, we endowed organisms with a marformycins biosynthetic pathway‐derived methyltransferase that efficiently converts tyrosine to OMeY in the presence of the co‐factor S‐adenosylmethionine. The resulting cells can produce and site‐specifically incorporate OMeY into proteins at much higher levels than cells exogenously fed OMeY. To understand the structural basis for the substrate selectivity of the transferase, we solved the X‐ray crystal structures of the ligand‐free and tyrosine‐bound enzymes. Most importantly, we have extended this OMeY biosynthetic system to both mammalian cells and the zebrafish model to enhance the utility of genetic code expansion. The creation of autonomous eukaryotes using a 21st amino acid will make genetic code expansion technology more applicable to multicellular organisms, providing valuable vertebrate models for biological and biomedical research.
- Open Access
- 25 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (26) , eabf2051
Harnessing the power of antibodies to fight bone metastasis
Precision modification of antibodies with bone-targeting moieties unleashes their potential for the treatment of bone metastases.
- 25 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (26) , eabf2051
Open AccessHarnessing the power of antibodies to fight bone metastasis
Precision modification of antibodies with bone-targeting moieties unleashes their potential for the treatment of bone metastases.
- 1 September 2017
- Published by Elsevier in International Journal of Refrigeration
- Vol. 81, 151-162
Dynamic modulation of voltage excitation angle to optimize energy consumption of refrigerator
- 1 September 2017
- Published by Elsevier in International Journal of Refrigeration
- Vol. 81, 151-162
Dynamic modulation of voltage excitation angle to optimize energy consumption of refrigerator